189 related articles for article (PubMed ID: 32396749)
1. The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells.
Peppicelli S; Andreucci E; Ruzzolini J; Bianchini F; Nediani C; Supuran CT; Calorini L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1185-1193. PubMed ID: 32396749
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis.
Andreucci E; Peppicelli S; Carta F; Brisotto G; Biscontin E; Ruzzolini J; Bianchini F; Biagioni A; Supuran CT; Calorini L
J Mol Med (Berl); 2017 Dec; 95(12):1341-1353. PubMed ID: 28929255
[TBL] [Abstract][Full Text] [Related]
3. The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy.
Andreucci E; Ruzzolini J; Peppicelli S; Bianchini F; Laurenzana A; Carta F; Supuran CT; Calorini L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):117-123. PubMed ID: 30362384
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells.
Temiz E; Koyuncu I; Durgun M; Caglayan M; Gonel A; Güler EM; Kocyigit A; Supuran CT
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198834
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Carbonic Anhydrase Using SLC-149: Support for a Noncatalytic Function of CAIX in Breast Cancer.
Mboge MY; Combs J; Singh S; Andring J; Wolff A; Tu C; Zhang Z; McKenna R; Frost SC
J Med Chem; 2021 Feb; 64(3):1713-1724. PubMed ID: 33523653
[TBL] [Abstract][Full Text] [Related]
6. Effect of Carbonic Anhydrase IX inhibitors on human endothelial cell survival.
Genah S; Angeli A; Supuran CT; Morbidelli L
Pharmacol Res; 2020 Sep; 159():104964. PubMed ID: 32485281
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs.
Carta F; Vullo D; Osman SM; AlOthman Z; Supuran CT
Bioorg Med Chem; 2017 May; 25(9):2569-2576. PubMed ID: 28347633
[TBL] [Abstract][Full Text] [Related]
8. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
9. Sulfamate inhibitor S4 influences carbonic anhydrase IX ectodomain shedding in colorectal carcinoma cells.
Hektoen HH; Ree AH; Redalen KR; Flatmark K
J Enzyme Inhib Med Chem; 2016 Oct; 31(5):779-86. PubMed ID: 26244271
[TBL] [Abstract][Full Text] [Related]
10. Combined 3-O-acetylbetulin treatment and carbonic anhydrase IX inhibition results in additive effects on human breast cancer cells.
Petrenko M; Güttler A; Funtan A; Keßler J; Emmerich D; Paschke R; Vordermark D; Bache M
Chem Biol Interact; 2021 Jan; 333():109326. PubMed ID: 33245928
[TBL] [Abstract][Full Text] [Related]
11. Perfusion-Based Bioreactor Culture and Isothermal Microcalorimetry for Preclinical Drug Testing with the Carbonic Anhydrase Inhibitor SLC-0111 in Patient-Derived Neuroblastoma.
Huo Z; Bilang R; Supuran CT; von der Weid N; Bruder E; Holland-Cunz S; Martin I; Muraro MG; Gros SJ
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328549
[TBL] [Abstract][Full Text] [Related]
12. Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors.
Shaldam M; Eldehna WM; Nocentini A; Elsayed ZM; Ibrahim TM; Salem R; El-Domany RA; Capasso C; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2021 Apr; 216():113283. PubMed ID: 33667848
[TBL] [Abstract][Full Text] [Related]
13. SLC-0111 enaminone analogs, 3/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX.
Eldehna WM; Abo-Ashour MF; Berrino E; Vullo D; Ghabbour HA; Al-Rashood ST; Hassan GS; Alkahtani HM; Almehizia AA; Alharbi A; Abdel-Aziz HA; Supuran CT
Bioorg Chem; 2019 Mar; 83():549-558. PubMed ID: 30471577
[TBL] [Abstract][Full Text] [Related]
14. The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy.
van Kuijk SJ; Gieling RG; Niemans R; Lieuwes NG; Biemans R; Telfer BA; Haenen GR; Yaromina A; Lambin P; Dubois LJ; Williams KJ
PLoS One; 2016; 11(8):e0161040. PubMed ID: 27513947
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents.
Eldehna WM; Abo-Ashour MF; Nocentini A; El-Haggar RS; Bua S; Bonardi A; Al-Rashood ST; Hassan GS; Gratteri P; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2019 Jan; 162():147-160. PubMed ID: 30445264
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX.
Bozdag M; Carta F; Ceruso M; Ferraroni M; McDonald PC; Dedhar S; Supuran CT
J Med Chem; 2018 Jul; 61(14):6328-6338. PubMed ID: 29962205
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Evaluation of Ureidosulfamate Carbonic Anhydrase IX/XII Inhibitors in the Treatment of Cancers.
Williams KJ; Gieling RG
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810330
[TBL] [Abstract][Full Text] [Related]
18. Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically.
Chafe SC; McDonald PC; Saberi S; Nemirovsky O; Venkateswaran G; Burugu S; Gao D; Delaidelli A; Kyle AH; Baker JHE; Gillespie JA; Bashashati A; Minchinton AI; Zhou Y; Shah SP; Dedhar S
Cancer Immunol Res; 2019 Jul; 7(7):1064-1078. PubMed ID: 31088846
[TBL] [Abstract][Full Text] [Related]
19. Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells.
Güttler A; Theuerkorn K; Riemann A; Wichmann H; Kessler J; Thews O; Bache M; Vordermark D
Oncol Rep; 2019 Apr; 41(4):2585-2594. PubMed ID: 30720123
[TBL] [Abstract][Full Text] [Related]
20. Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers.
Marks IS; Gardeen SS; Kurdziel SJ; Nicolaou ST; Woods JE; Kularatne SA; Low PS
Mol Pharm; 2018 Jun; 15(6):2289-2296. PubMed ID: 29715036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
